entertainment -WSS

entertainment

author：knowledge 2025-10-04 03:59:40 - browse：94417

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

Roche said Monday it was buying Telavant Holdings for $7.1 billion upfront, picking up a promising experimental therapy for inflammatory bowel diseases.

Telavant is owned by Roivant Sciences, with Pfizer holding a minority stake. The deal will allow Roche to develop the therapy, called RVT-3101, and, pending approval, sell it in the United States and Japan. Pfizer holds the commercial rights in other parts of the world.

The “Roi” in Roivant stands for “return on investment” and with this deal, the biotech, founded by Republican presidential candidate Vivek Ramaswamy but now run by CEO Matt Gline, certainly delivered. Last December, it essentially acquired RVT-3101 from Pfizer for $45 million and a commitment to invest in the drug’s development. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： FDA greenlights medical device to combat bladder issues

hotspot

WSS

ProMED sees offers of support, but its future remains unclear

Eye stem cell transplant could help restore vision in injured people

An interview with Robert F. Kennedy Jr. on vaccines

FDA advisory panel to debate high blood pressure devices

Baltimore teen accused of firing into crowd during block party mass shooting

Vivek Ramaswamy made waves in the debate, much as in biotech

entertainment

entertainment

knowledge

Jerome Adams on the need for new antivirals for Covid

New details revealed about Purdue's marketing of OxyContin

Cancer drug shortages should be causing more outrage

Hilary may become 1st tropical storm to make landfall in California in 84 years

Anesthesiologist group: stop taking Ozempic before surgery

National associations that represent hospice owe an apology

Novavax promises a turnaround & Lilly roils the obesity market

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

In age of alternative facts, a scholarly course on calling out crap

Can U.S. cancer drug shortages be fixed?

entertainment

FDA advisory panel to debate high blood pressure devices

Republicans love RFK Jr. What's that tell us about health in 2024?

National associations that represent hospice owe an apology

Trans patients at the end of life deserve respect and dignity

Vivek Ramaswamy made waves in the debate, much as in biotech

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

leisure time

focus

hotspot

hotspot